Name | Title | Contact Details |
---|
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.
Loyale is reinventing the way healthcare providers engage with their patients financially. With Loyale`s end-to-end suite of solutions, providers of all types and configurations are elevating their patients` financial experiences to a level that compares with their clinical experiences. With Loyale, providers build durable, trusting relationships with patients. They also increase revenues, reduce staff time & stress, and minimize bad debt.
Medafor is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symbion Research International, Inc is a Newbury Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A-Dec, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newberg, OR. To find more information about A-Dec, Inc., please visit www.a-dec.com